MYC and breast cancer: Consistently, in vivo data in the BALB/c mouse models of mammary tumors and bone osteolysis supported the anti-tumor capability of c-Myc CM that significantly inhibited the growth of mammary tumors and the destruction of trabecular bone in the tibia (Figure 3D-E, Figure S3C).